[HTML][HTML] Mesenchymal stromal cells and toll-like receptor priming: a critical review

M Najar, M Krayem, N Meuleman, D Bron… - Immune …, 2017 - synapse.koreamed.org
Mesenchymal Stromal Cells (MSCs) are potential cellular candidates for several
immunotherapy purposes. Their multilineage potential and immunomodulatory properties …

Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections

V Johnson, T Webb, A Norman, J Coy, J Kurihara… - Scientific reports, 2017 - nature.com
Chronic bacterial infections associated with biofilm formation are often difficult to resolve
without extended courses of antibiotic therapy. Mesenchymal stem cells (MSC) exert …

Primed mesenchymal stem cells alter and improve rat medial collateral ligament healing

EE Saether, CS Chamberlain, E Aktas… - Stem Cell Reviews and …, 2016 - Springer
Cell therapy with mesenchymal stem cells (MSCs) can improve tissue healing. It is possible,
however, that priming MSCs prior to implantation can further enhance their therapeutic …

[HTML][HTML] Evaluation of human adipose-derived mesenchymal stromal cell Toll-like receptor priming and effects on interaction with prostate cancer cells

CM Rivera-Cruz, ML Figueiredo - Cytotherapy, 2023 - Elsevier
Background aims Mesenchymal stromal cells (MSCs) are a multipotent cell population of
clinical interest because of their ability to migrate to injury and tumor sites, where they may …

[HTML][HTML] Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming

CA Dumitru, H Hemeda, M Jakob, S Lang… - The FASEB …, 2014 - ncbi.nlm.nih.gov
Mesenchymal stem/stromal cells (MSCs) are emerging as important regulators of innate and
adaptive immunity. In this context, both proinflammatory and anti-inflammatory effects have …

Immuno-metabolic modulation of liver oncogenesis by the tryptophan metabolism

V Trézéguet, H Fatrouni, AJ Merched - Cells, 2021 - mdpi.com
Metabolic rewiring in tumor cells is a major hallmark of oncogenesis. Some of the
oncometabolites drive suppressive and tolerogenic signals from the immune system, which …

Exon array analysis reveals genetic heterogeneity in atypical femoral fractures. A pilot study

I Pérez-Núñez, JL Pérez-Castrillón… - Molecular and cellular …, 2015 - Springer
Atraumatic subtrochanteric and diaphyseal (atypical) femoral fractures are a rare, but
important adverse event in patients treated with potent anti-resortive agents. The …

Enzalutamide-resistant progression of castration-resistant prostate cancer is driven via the JAK2/STAT1-dependent pathway

Y Luo, X Yang, SP Basourakos, X Zuo… - Frontiers in molecular …, 2021 - frontiersin.org
Previous studies showed that CXCR7 expression was upregulated after enzalutamide (ENZ)
treatment, and an increased level of CXCR7 could increase the invasion, migration, and …

Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine–induced signaling and limiting chondrocyte responses during murine inflammatory arthritis

X Liu, BA Croker, IK Campbell, SJ Gauci… - Arthritis & …, 2014 - Wiley Online Library
Objective To examine the impact of the gp130 cytokine family on murine articular cartilage
and to explore a potential regulatory role of suppressor of cytokine signaling 3 (SOCS‐3) in …

New cell-based therapy paradigm: induction of bone marrow-derived multipotent mesenchymal stromal cells into pro-inflammatory MSC1 and anti-inflammatory MSC2 …

AM Betancourt - Mesenchymal Stem Cells-Basics and Clinical …, 2013 - Springer
Cell-based therapies (CBTs) are quickly taking hold as a revolutionary new approach to
treat many human diseases. Among the cells used in these treatments, multipotent …